| abstract |
The present invention relates to novel compounds of formula I, their pharmaceutically acceptable derivatives, tautomeric forms, isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to a process for the synthesis of the novel compounds of formula I, their pharmaceutically acceptable derivatives, tautomers, isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention also includes pharmaceutical compositions comprising the novel compounds of formula I and the treatment of one or more conditions or diseases that can be controlled or normalized through inhibition of sodium glucose cotransporter-2 (SGLT-2). Provide a method or preventive method. |